aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
MedMen Enterprises is a leading American-Canadian cannabis firm focused on the cultivation, manufacturing, and retail of cannabis products. The company serves the biotechnology and pharmaceutical industries in the United States and Canada, aiming to redefine the cannabis experience through high-quality products and innovative retail environments.
MedMen has achieved significant milestones, including the establishment of licensed cannabis facilities and a strong retail presence. The company's impact is evident in its contribution to the mainstream acceptance of cannabis, with notable investors supporting its mission to transform the industry.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Retail, Cannabis
Technology
Agriculture
Revenue Type(s)
Transactional
Customer Type(s)
Consumers
Geographic Exposure
United States
When was MedMen founded?
MedMen was founded in 2010.
Where is MedMen’s headquarters located?
MedMen’s headquarters is located in Culver City, CA, US.
How many employees does MedMen have?
MedMen has 428 employees as of Feb 6, 2024.
How much has MedMen raised to-date?
As of July 05, 2023, MedMen has raised a total of $499M (USD) since Apr 11, 2022.
Add Comparison
Total Raised to Date
$499M
USD
Last Update Apr 11, 2022
Total Employees Over Time
428
As of Feb 2024
MedMen Address
10115 Jefferson Boulevard
Culver City,
California
90232
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts